Suchergebnisse - "Heil, Emily L"

PubPharm (144)

61

Rifabutin Use in Staphylococcus Biofilm Infections : A Case Series

enthalten in: Antibiotics (Basel, Switzerland) | 2020

von Doub, J. | Heil, E. | Ntem-Mensah, A. | +2

62

Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection

enthalten in: Pharmacotherapy | 2020

von Vega, A. | Heil, E. | Blackman, A. | +4

CommentIn: Pharmacotherapy. 2020 Sep;40(9):984. - PMID 33112453

63

Recommended Revisions to the National SEP-1 Sepsis Quality Measure : A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper

enthalten in: Pharmacotherapy | 2020

von Heil, E. | Aitken, S. | Nix, D. | +7

CommentOn: Clin Infect Dis. 2021 Feb 16;72(4):541-552. - PMID 32374861

64

The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for Enterobacteriaceae : Let's Not Let Perfect Be the Enemy of Really Good

enthalten in: Journal of clinical microbiology | 2020

von Pogue, J. | Heil, E.

65

Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock

enthalten in: Pharmacotherapy | 2020

von Masich, A. | Kalaria, S. | Gonzales, J. | +5

66

A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients

enthalten in: Antimicrobial agents and chemotherapy | 2020

von Kalaria, S. | Gopalakrishnan, M. | Heil, E.

ErratumIn: Antimicrob Agents Chemother. 2021 Mar 18;65(4):. - PMID 33737314

67

The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir : a case report

enthalten in: Antiviral therapy | 2020

von Blackman, A. | Heil, E. | Devanathan, A. | +1

68

Antimicrobial usage at a large teaching hospital in Lusaka, Zambia

enthalten in: PloS one | 2020

von Masich, A. | Vega, A. | Callahan, P. | +10

69

Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen

enthalten in: SAGE open medicine | 2020

von Mouradjian, M. | Heil, E. | Sueng, H. | +1

70

Recommended Revisions to the National SEP‐1 Sepsis Quality Measure : A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper

enthalten in: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | 2020

von Heil, E. | Aitken, S. | Nix, D. | +6